New Newsletter Explores Innovation and Technology Commercialization at the University of Rochester
The first issue of UR Ventures Technology Review is out and available here.
The first issue of UR Ventures Technology Review is out and available here.
The 17 June installment of the Good Advice: Case Studies in Clinical Research, Regulation, and the Law will examine the fascinating history of the COX-2 litigation. Presented by M. Kerry O’Banion, MD, PhD and Thomas Jackson, JD and Immediate Past President of the University of
Camber NeuroTherapeutics Inc., founded based on discoveries made in the laboratories of Harris “Handy” A. Gelbard, M.D., Ph.D. and Stephen Dewhurst, Ph.D., plans to attack the cognitive component of neurodegenerative diseases using a completely new approach: stopping the inflammation in the brain, so-called neuroinflammation, that
Rochester, NY – May 15, 2015 – EagleDream Health, Inc., a healthcare analytics software solutions company today announced it has acquired Focused Medical Analytics, LLC, (FMA) a company specializing in data analysis to identify, understand, and address clinical variation. The acquisition strengthens EagleDream Health’s analytics solution
17 April 2015 CNN Money Panther Biotechnology, Inc. (OTC PINK: PBYA), a biotechnology company specializing in the development of enhanced therapeutics for the treatment of neoplastic disorders, is pleased to announce today that it has entered into an exclusive global license agreement with the University
Outstanding young talents and innovative thinkers from all disciplines up to 35 years of age are invited to apply for an opportunity to present their research project, business plan, entrepreneurial or social initiative that is relevant to the world today — in 3 minutes! More
The SPARK Entrepreneurs club is holding a 24-hour Red Paperclip Challenge for students at all levels of study from Friday, March 20 to Saturday, March 21. Event registration starts at 6:00 p.m. on Friday in the Rettner Hall atrium. The event will kick off with
Research that has transformed scientists’ understanding of the brain and neurodegenerative diseases like Alzheimer’s has been awarded the 2014 Newcomb Cleveland Prize of the American Association for the Advancement of Science (AAAS). The Association’s oldest honor, the prize annually recognizes the author or authors of
Amy Or, Wall Street Journal, 17 December 2014 Norwest Venture Partners’ portfolio company iCardiac Technologies Inc. may have a way to help pharmaceutical companies detect which experimental drugs might flat line over cardiac concerns. The Rochester, N.Y.-based company recently completed a study in collaboration with
Chunlei Guo, professor of optics, is scheduled to be a guest on Science Friday today at 2 p.m. Guo is set to talk about his research on using lasers to create superhydrophobic metals. The show airs on NPR. Tune in locally to WXXI AM1370.
The National Science Foundation today announced that the University of Rochester has been selected for an I-Corps site Award. This 3-year, $300,000 award will give Rochester the resources necessary to support further development of as many as 30 projects per year. Funds may be used
Dr. Goldman’s human glial mouse model has been written up in New Scientist. The idea is not to mimic fiction, but to advance our understanding of human brain diseases by studying them in whole mouse brains rather than in dishes. The altered mice still have
Four prominent Rochester researchers shared the state of their research and their experiences discovering and developing useful drugs. Mark Noble, Ph.D., (Biomedical Genetics), Paul Dunman, Ph.D. (Microbiology & Immunology), Harold Smith, Ph.D. (Biochemistry & Biophysics), and Richard Phipps, Ph.D. (Environmental Medicine) all spoke about some
High Tech Rochester’s Lennox Tech Enterprise Center, by virtue of its association with the University of Rochester, is a tax-free zone under the new START-UP NY economic development program. Taking advantage of HTR’s designation, PharmAdva LLC (www.pharmadva.com), a startup healthcare technology company with roots at
The University of Rochester has been identified by the journal Nature Biotechnology as one of the top 10 universities in the nation for the impact of its life sciences research. “This recognition reflects not only the University’s success in attracting federal research funding, but our ability to
They started with 6,932 applications from 96 countries and all 50 states. On 30 October 2014, the 11 finalists pitched their business plans to the judges. And the results are . . . Click here